In the News

Read, discover, share

In the News

Mar 8

Amniotic Fluid Products Probably Don’t Contain Stem Cells, but May Still Modulate Healing

In vivo amniotic fluid is known to contain growth factors and mesenchymal stem cells (MSCs), which prior research has suggested may aid in tissue healing. Several companies have injectable amniotic fluid products  (AFPs) on the market based on this  prior research, but it’s unclear exactly what the composition of these AFPs is and whether they contain viable MSCs that could participate in healing. To clarify these lingering questions, upcoming TOBI conference speaker Dr. Panero and several of his colleagues at...

Feb 22

New Biologics Guidelines for Low Back Pain

[section_tc][column_tc span='12'][text_tc trigger_pt='0' duration='1000' delay='0']The use of regenerative medicine has been expanding as its power to help heal patients has become increasingly apparent. However, the decision about what and who to treat with these therapeutic compounds can be tricky, especially given the variable and occasionally scarce data about certain applications. TOBI Alumni Faculty, Annu Navani has spearheaded a massive effort in collaboration with the American Society of Interventional Pain Physicians (ASIPP) to bring clarity to the use of biologic therapies...

Jan 20

The Influence of Naproxen on Biological Factors in Leukocyte-Rich PRP: A Prospective Study

Chahla et al 2019 (NSAIDS) Leukocyte-Rich Platelet-Rich Plasma (LR-PRP) consists of blood plasma with higher concentrations of platelets and leukocytes than typically available in a normal blood draw, and is commonly used to treat musculoskeletal injuries through regenerative processes in the body.  Oftentimes, concentrations of platelets and leukocytes are highly variable in a given therapeutic sample, as well as the methods of preparing that biological product and the demographic characteristics from which the blood sample was drawn. All these factors,...